Clinical trial
Effect of Negative-Pressure Drainage Versus Pancreatic Duct Stenting for Preventing Pancreatitis After Endoscopic Papillectomy for Duodenal Papillary Tumors: A Prospective, Multicenter, Randomized Controlled Trial
NCT07446543 is registered in ClinicalTrials.gov with Cui Xiaobing as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Negative-Pressure Drainage Versus Pancreatic Duct Stenting for Preventing Pancreatitis After Endoscopic Papillectomy for Duodenal Papillary Tumors: A Prospective, Multicenter, Randomized Controlled Trial
- Lead sponsor
- Cui Xiaobing
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- March 20, 2026
- Completion date
- June 30, 2029
- Enrollment
- 132 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
ampulla of vater neoplasms, ampullary adenoma, ampullary carcinoma